The American Association for Clinical Chemistry’s (AACC) 2025 meeting, formerly known as the AACC Annual Scientific Meeting & Clinical Lab Expo, will be held in Chicago from July 27 to 31, in partnership with the Canadian Society of Clinical Chemists (CSCC). The meeting will address the clinical integration of artificial intelligence, medical misinformation, and health risks associated with plastics, as well as genomics and microbiome medicine for personalised healthcare. Experts will focus on genomics strategies for the approximately 30 million Americans impacted by rare diseases, while also examining the challenges of implementing the 950 machine-learning-enabled devices already approved by the Food and Drug Administration. Presentations will include strategies for combating misinformation and insights into the human microbiome’s role in various disease states.
Advancing Laboratory Medicine
The ADLM 2025 meeting, held in partnership with the Canadian Society of Clinical Chemists, will address timely topics including clinical AI integration, medical misinformation, and health risks posed by plastics, alongside genomics and microbiome medicine for personalised healthcare. Research strategies for unleashing the potential of genomics will be a key focus, offering new hope for patients with rare diseases, which collectively impact up to 30 million Americans. Dr. Heidi L. Rehm will present strategies, technologies and analysis methods for identifying the genetic causes of rare disease, alongside approaches to global data sharing and the development of new treatment and testing modalities.
The meeting will also examine the potential of artificial intelligence in healthcare, noting that the Food and Drug Administration has approved 950 machine-learning-enabled devices, though clinical use remains limited despite its potential in reducing the amount of unpaid work undertaken by healthcare workers. Dr. Judy Wawira Gichoya will examine the challenges of implementing AI in healthcare and present examples of algorithms that were deployed and subsequently retracted, informing future integration efforts.
Professor Timothy Caulfield will deliver a plenary describing the most pernicious falsehoods currently circulating and the cultural forces behind them, including celebrity culture, fearmongering, and cognitive bias, also providing steps individuals and organisations can take to prevent the spread of misinformation, including the twisting of scientific findings. The human microbiome, and its key role in human health, allergic responses, neurological and metabolic disorders, will also be a subject of discussion. Dr. Jack Gilbert will share insights from findings regarding the collection of microbes and their impact on various disease states.
Genomics and Rare Disease Genomics will be a key area of focus, offering new hope for the approximately 30 million Americans impacted by rare diseases. Dr. Heidi L. Rehm will present strategies, technologies, and analysis methods being used to identify the genetic causes of these diseases, as well as approaches to global data sharing. These efforts aim to facilitate the development of new treatment and testing modalities based on genomic understanding.
The meeting will also address the potential of artificial intelligence (AI) in healthcare, noting that 950 machine-learning-enabled devices have received approval from the Food and Drug Administration. Despite this number, clinical use remains limited, even though AI offers the potential to reduce the amount of unpaid work undertaken by healthcare workers. Dr. Judy Wawira Gichoya will examine the challenges associated with implementing AI in healthcare and will present examples of algorithms that were deployed and subsequently retracted to inform future integration efforts.
Professor Timothy Caulfield will deliver a plenary session describing prevalent falsehoods and the cultural forces that contribute to their spread, including influences such as celebrity culture, fearmongering, and cognitive bias. He will also provide actionable steps for individuals and organisations to prevent the dissemination of misinformation, including instances where scientific findings are deliberately distorted.
The human microbiome, and its crucial role in human health, allergic responses, neurological and metabolic disorders, will also be discussed. Dr. Jack Gilbert will share insights derived from findings regarding the collection of microbes and their impact on a range of disease states.
Artificial Intelligence in Healthcare
The potential of artificial intelligence (AI) in healthcare will also be examined, noting that the Food and Drug Administration has approved 950 machine-learning-enabled devices, though clinical use remains limited despite its potential in reducing the amount of unpaid work undertaken by healthcare workers. Dr. Judy Wawira Gichoya will examine the challenges of implementing AI in healthcare and present examples of algorithms that were deployed and subsequently retracted to inform future integration efforts.
Professor Timothy Caulfield will deliver a plenary describing the most pernicious falsehoods currently circulating and the cultural forces behind them, including celebrity culture, fearmongering, and cognitive bias, also providing steps individuals and organisations can take to prevent the spread of misinformation, including the twisting of scientific findings. The human microbiome, and its key role in human health, allergic responses, neurological and metabolic disorders, will also be a subject of discussion. Dr. Jack Gilbert will share insights from findings regarding the collection of microbes and their impact on a range of disease states.
More information
External Link: Click Here For More
